Pharma-Bio Serv services the Puerto Rico, United States, Europe and Latin America markets. Pharma-Bio Serv's core business is FDA and international agencies regulatory compliance consulting related services. The Company's global team includes leading engineering and life science professionals, quality assurance managers and directors.
Company profile
Ticker
PBSV
Exchange
Website
CEO
Victor Sanchez
Employees
Location
Fiscal year end
Industry (SIC)
Former names
LAWRENCE CONSULTING GROUP INC
SEC CIK
Corporate docs
Subsidiaries
Pharma-Bio Serv PR, Inc. • Pharma-Bio Serv US, Inc. • Pharma Serv, Inc. • Scienza Labs, Inc. • Pharma-Bio Serv S.L. • Pharma-Bio Serv Brasil Servicos de Consultoria Ltda. ...
IRS number
200653570
PBSV stock data
Latest filings (excl ownership)
8-K
Results of Operations and Financial Condition
17 Mar 23
10-Q
2023 Q1
Quarterly report
17 Mar 23
8-K
Pharma-Bio Serv Announces Special Dividend
1 Mar 23
10-K/A
2022 FY
Annual report (amended)
28 Feb 23
8-K
Amendments to Articles of Incorporation or Bylaws
9 Feb 23
8-K
Other Events
7 Feb 23
8-K
Pharma-Bio Serv Announces Full Year Results
30 Jan 23
10-K
2022 FY
Annual report
30 Jan 23
8-K
Results of Operations and Financial Condition
14 Sep 22
10-Q
2022 Q3
Quarterly report
14 Sep 22
Latest ownership filings
Financial summary
| Quarter (USD) | Jan 23 | Oct 22 | Jul 22 | Apr 22 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Oct 22 | Oct 21 | Oct 20 | Oct 19 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 7.23 mm | 7.23 mm | 7.23 mm | 7.23 mm | 7.23 mm | 7.23 mm |
| Cash burn (monthly) | 2.41 mm | 677.19 k | (no burn) | (no burn) | (no burn) | (no burn) |
| Cash used (since last report) | 4.23 mm | 1.19 mm | n/a | n/a | n/a | n/a |
| Cash remaining | 2.99 mm | 6.04 mm | n/a | n/a | n/a | n/a |
| Runway (months of cash) | 1.2 | 8.9 | n/a | n/a | n/a | n/a |
Institutional ownership, Q1 2021
| 13F holders | Current |
|---|---|
| Total holders | 0 |
| Opened positions | 0 |
| Closed positions | 0 |
| Increased positions | 0 |
| Reduced positions | 0 |
| 13F shares | Current |
|---|---|
| Total value | 0.00 |
| Total shares | 0.00 |
| Total puts | 0.00 |
| Total calls | 0.00 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|
Recent insider trades
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 6 Mar 23 | Pedro J Lasanta | Common Stock | Payment of exercise | Dispose F | No | No | 1.15 | 7,167 | 8.24 k | 119,188 |
| 6 Mar 23 | Pedro J Lasanta | Common Stock | Option exercise | Acquire M | No | No | 0.99 | 8,325 | 8.24 k | 126,355 |
| 6 Mar 23 | Pedro J Lasanta | Common Stock | Payment of exercise | Dispose F | No | No | 1.15 | 76,522 | 88.00 k | 118,030 |
| 6 Mar 23 | Pedro J Lasanta | Common Stock | Option exercise | Acquire M | No | No | 0.88 | 100,000 | 88.00 k | 194,552 |
| 6 Mar 23 | Pedro J Lasanta | Stock Option Common Stock | Option exercise | Dispose M | No | No | 0.99 | 8,325 | 8.24 k | 16,675 |
| 6 Mar 23 | Pedro J Lasanta | Stock Option Common Stock | Option exercise | Dispose M | No | No | 0.88 | 100,000 | 88.00 k | 0 |
| 6 Mar 23 | Altura Victor Sanchez | Common Stock | Payment of exercise | Dispose F | No | No | 1.15 | 7,167 | 8.24 k | 11,382 |
| 6 Mar 23 | Altura Victor Sanchez | Common Stock | Option exercise | Acquire M | No | No | 0.99 | 8,325 | 8.24 k | 18,549 |
| 6 Mar 23 | Altura Victor Sanchez | Stock Option Common Stock | Option exercise | Dispose M | No | No | 0.99 | 8,325 | 8.24 k | 16,675 |
| 10 Jan 23 | Perlysky Dov | Stock Option Common Stock | Grant | Acquire A | No | No | 0 | 20,000 | 0.00 | 20,000 |
Press releases
Pharma-Bio Serv Announces Results for the Quarter Ended January 31, 2023
17 Mar 23
Pharma-Bio Serv Announces Special Dividend
1 Mar 23
Pharma-Bio Serv Retains Investment Banking Firm ACP Capital to Provide Investment Banking and M&A Advisory Services
7 Feb 23
Pharma-Bio Serv Announces Full Year Results
30 Jan 23